AVENUE SOLUTIONS

Lobbying for JAZZ PHARMACEUTICALS, INC. · Specialty pharmaceuticals

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing; Expiring healthcare extenders; Issues related to BIOSECURE

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.